Blood collection tubes market seen reaching $10.49 billion by 2030

The blood collection tubes market is projected to grow from $7.45 billion in 2026 to $10.49 billion by 2030, according to The Business Research Company. Rising chronic disease testing, automated lab workflows and demand for contamination-free sample handling are driving the outlook.

Why it matters: - Blood collection tubes are a core part of diagnostic testing, so market growth signals more demand for lab supplies tied to chronic disease monitoring, hospital testing and outpatient care. - The forecast suggests continued investment in sample handling, automated workflows and tube innovation through 2030.

What happened: - The Business Research Company released a market report projecting the blood collection tubes market will grow from $7.45 billion in 2026 to $10.49 billion by 2030. - The report puts the market’s compound annual growth rate at 8.9% for the 2026-2030 period. - The company also estimated the market at $6.87 billion in 2025 and $7.45 billion in 2026, implying 8.4% growth during the historical period.

The details: - The report cites rising diagnostic testing volumes, growth in hospital laboratory services, higher chronic disease prevalence, standardized blood collection practices and mass-produced plastic tubes as drivers of past growth. - Future growth is linked to demand for advanced diagnostic testing, automated laboratory workflows, more outpatient and ambulatory testing centers, contamination-free sample handling and new tube materials and additives. - The report says plastic blood collection tubes are gaining use, along with pre-labeled and color-coded tubes, vacuum-based collection systems and specialized diagnostic tubes. - Blood collection tubes are sterile test tubes made of glass or plastic and sealed with colored rubber or plastic caps. - The tubes are used to collect and transport blood specimens for laboratory analysis while preserving sample integrity for accurate diagnostics. - Chronic diseases such as diabetes, cancer and tuberculosis are a major demand driver because they require frequent blood testing and monitoring. - Lifestyle factors including tobacco use, secondhand smoke exposure, poor diet and physical inactivity contribute to higher chronic disease rates. - Infectious disease incidence is also supporting demand for diagnostic testing and blood collection devices. - In February 2024, the World Health Organization projected new cancer cases will exceed 35 million by 2050, up 77% from 20 million in 2022. - North America held the largest share of the blood collection tubes market in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report is available as a full market report, and a free sample is also offered.

Between the lines: - The forecast points to a market shifting from basic collection supplies toward products that reduce contamination risk, improve traceability and fit higher-throughput lab systems. - Regional leadership remains with North America, but faster expansion in Asia-Pacific suggests future demand growth will be tied to healthcare buildout and expanding diagnostic access in emerging markets.

What's next: - The market is expected to keep expanding as lab automation spreads and testing volumes rise across chronic and infectious disease care. - The report highlights continued product development in tube materials, additives and specialized formats as a key competitive theme. - The Business Research Company says its 2026 market reports include TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables.